How does the BALANCE study work?

If you qualify for and participate in the study, you will be randomly assigned to receive either the investigational drug or placebo via subcutaneous injection into the skin. (You have a greater chance of receiving the study therapy compared to the placebo).
To help keep the study results as accurate as possible, you, the doctor, and staff conducting the study will not know if you are being given the investigational drug or the placebo (unless there is an emergency).
Your total participation in the study will be for approximately 16 months, (22 visits total over 70 weeks) with only two visits needed onsite including screening for eligibility, treatment, and follow-up.
Over 53 weeks, you will receive 13 doses of the study therapy or placebo.